Skip to main content
. 2011 Jan 10;22(7):1636–1643. doi: 10.1093/annonc/mdq645

Figure 1.

Figure 1.

Patient cohort [*other T-cell neoplasms include other T-cell leukemias, natural killer (NK) cell leukemia, lymphoblastic lymphoma, extranodal NK/T-cell lymphoma, primary cutaneous peripheral T-cell lymphomas, mycosis fungoides, Sezary syndrome and chronic lymphoproliferative disorder of NK cells; **PTCL-NOS, peripheral T-cell lymphoma, not otherwise specified; AITL, angioimmunoblastic T-cell lymphoma; HSTL, hepatosplenic T-cell lymphoma; EATL, enteropathy-associated T-cell lymphoma; ALCL, anaplastic large cell lymphoma; †Kim et al. 20].